BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/14/2026 3:57:26 AM | Browse: 5 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 119040
Country China
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Cohort Study
Article Title Prognostic factors and optimal timing for initiating adjuvant chemotherapy in stage IIIC gastric cancer
Manuscript Source Unsolicited Manuscript
All Author List Jun-Wei Wu, Fan Li, Shi-Dian Wang, Yu-Kun Guo, Bing-Huang Li, Xin Zhou, Guo-Qiang Su and Chuan-Hui Lu
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China No. 81970462
Key Medical and Health Project of Xiamen No. 3502Z20204001
Corresponding Author Chuan-Hui Lu, /, The Graduate School of Fujian Medical University, No. 1 Xuefu North Road, Shangjie Town, Minhou County, Fuzhou 350122, Fujian Province, China. 46601533@qq.com
Key Words Gastric cancer; Chemotherapy; Disease-free survival; Prognosis; Time factors
Core Tip We identified age ≥ 60 years, carcinoembryonic antigen ≥ 5.0 μg/L, metastatic lymph node ratio ≥ 0.5 and time interval (TI) from surgery to initiation of adjuvant chemotherapy are independent risk factors for postoperative recurrence. Crucially, our findings demonstrate that initiating adjuvant chemotherapy within 6 weeks of surgery significantly improves disease-free survival in stage IIIC patients. Notably, the S-1 plus oxaliplatin regimen exhibits significant time-sensitivity, with an optimal window of within 6 weeks. Whereas the capecitabine plus oxaliplatin regimen does not. These insights provide a rationale for optimizing individualized therapeutic strategies for this high-risk subgroup.
Citation Wu JW, Li F, Wang SD, Guo YK, Li BH, Zhou X, Su GQ, Lu CH. Prognostic factors and optimal timing for initiating adjuvant chemotherapy in stage IIIC gastric cancer. World J Gastrointest Oncol 2026; In press
Received
2026-01-21 06:40
Peer-Review Started
2026-01-21 06:41
First Decision by Editorial Office Director
2026-01-27 07:56
Return for Revision
2026-01-27 11:39
Revised
2026-02-09 08:13
Publication Fee Transferred
2026-02-14 16:01
Second Decision by Editor
2026-04-14 02:36
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-04-14 03:57
Articles in Press
2026-04-14 03:57
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com